Jennison Associates’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-32,987
Closed -$7.99M 602
2023
Q1
$7.99M Sell
32,987
-25,969
-44% -$6.29M 0.01% 413
2022
Q4
$17.1M Sell
58,956
-54,544
-48% -$15.8M 0.02% 340
2022
Q3
$7.38M Sell
113,500
-68,946
-38% -$4.48M 0.01% 415
2022
Q2
$13.1M Buy
+182,446
New +$13.1M 0.01% 365
2020
Q3
Sell
-177,565
Closed -$20.1M 661
2020
Q2
$20.1M Sell
177,565
-47,369
-21% -$5.36M 0.02% 295
2020
Q1
$15M Sell
224,934
-51,496
-19% -$3.44M 0.02% 289
2019
Q4
$25.2M Buy
276,430
+741
+0.3% +$67.5K 0.03% 281
2019
Q3
$23.8M Sell
275,689
-29,204
-10% -$2.52M 0.03% 293
2019
Q2
$32M Sell
304,893
-6,127
-2% -$642K 0.03% 273
2019
Q1
$39M Buy
311,020
+29,949
+11% +$3.75M 0.04% 264
2018
Q4
$31.7M Buy
281,071
+57,700
+26% +$6.5M 0.04% 274
2018
Q3
$47.8M Buy
223,371
+61,586
+38% +$13.2M 0.04% 259
2018
Q2
$45.3M Sell
161,785
-66,873
-29% -$18.7M 0.04% 277
2018
Q1
$26.7M Buy
228,658
+24,458
+12% +$2.86M 0.03% 348
2017
Q4
$18.7M Buy
+204,200
New +$18.7M 0.02% 411
2015
Q4
Sell
-189,208
Closed -$11.5M 701
2015
Q3
$11.5M Buy
189,208
+1,069
+0.6% +$65.1K 0.01% 491
2015
Q2
$14.7M Buy
188,139
+1,363
+0.7% +$106K 0.01% 483
2015
Q1
$12.7M Buy
186,776
+85,924
+85% +$5.83M 0.01% 480
2014
Q4
$9.35M Sell
100,852
-4,116
-4% -$382K 0.01% 486
2014
Q3
$11.1M Buy
104,968
+113
+0.1% +$11.9K 0.01% 471
2014
Q2
$15M Sell
104,855
-8,869
-8% -$1.27M 0.01% 448
2014
Q1
$17.2M Buy
113,724
+563
+0.5% +$84.9K 0.02% 449
2013
Q4
$20.8M Sell
113,161
-12,203
-10% -$2.24M 0.02% 443
2013
Q3
$27.7M Buy
125,364
+1,253
+1% +$277K 0.03% 395
2013
Q2
$21.7M Buy
+124,111
New +$21.7M 0.02% 422